Global Insulin Delivery Systems Market 2016-2020; New Report Launched

DrugPipeline.net has announced the addition of “Global Insulin Delivery Systems Market 2016-2020” research report to their website DrugPipeline.net

Logo

Bangalore, Karnataka -- (SBWire) -- 09/06/2016 --The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to patients.

Report forecast the global insulin delivery systems market to grow at a CAGR of 5.11% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global insulin delivery systems market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of insulin delivery systems.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Insulin Delivery Systems Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Novo Nordisk
- Sanofi
- BD
- Eli Lilly
- Medtronic

Other prominent vendors
- Animas
- Beta Bionics
- Cellnovo
- Copernicus
- Dance Biopharm
- Debiotech
- InsuJet
- Insulet
- MannKind
- Owen Mumford
- Roche
- SHL
- SOOIL
- Tandem Diabetes Care
- Valeritas
- West Pharma
- Ypsomed

Market driver
- Paradigm shift of patient pool from hospitals to specialty clinics
- For a full, detailed list, view our report

Market challenge
- High cost of insulin devices and competitive pricing scenario
- For a full, detailed list, view our report

Market trend
- Inhalers to revolutionize insulin delivery
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 81 pages "Global Insulin Delivery Systems Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Market segmentation by product, Market segmentation by end-user, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-insulin-delivery-systems-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.

Media Relations Contact

Sudeep Chakravarty
Director - Operations
DrugPipeline.net
302-703-7787
http://www.drugpipeline.net/technavio/global-insulin-delivery-systems-market-2016-2020

View this press release online at: http://rwire.com/720440